Purchase Order 75N95A19P00157

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to Biotek Instruments, Inc. valued at $24,999.00 on August 15, 2017. The order is a firm fixed price commercial acquisition with no set-aside designation. Work is performed in Winooski, Vermont. The ultimate completion date is August 14, 2018.</p>

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to Biotek Instruments, Inc. on July 15, 2019, with a ceiling value of $24,995.00. The order carries no set-aside designation. Place of performance is Winooski, Vermont. The ultimate completion date is July 14, 2020.</p>

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to Biotek Instruments, Inc. for $5,113.00 on December 27, 2017, for equipment and maintenance/repair services related to medical and scientific instruments. Work is performed in Bethesda, Maryland. The order carries a firm fixed price and no small business set-aside. Ultimate completion is scheduled for April 21, 2018.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Biotek Instruments, Inc. for $66,876.75 on September 28, 2020. The order covers a cell imaging multi-mode microplate reader equivalent in specifications to the BioTek Cytation5. Performance occurs in Winooski, Vermont, with an ultimate completion date of December 31, 2020. The purchase order was issued under firm fixed price terms with no small business set-aside.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Biotek Instruments, Inc. valued at $23,783.98 on September 13, 2017. No set-aside was used. Place of performance is Winooski, Vermont. The order is priced on a firm fixed-price basis with an ultimate completion date of October 12, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Biotek Instruments, Inc. for $16,706.00 in lab equipment on August 20, 2020, with ultimate completion on September 17, 2020. The order, issued firm fixed price with no set-aside, supports de-obligation of expiring FY20 funding per NIH OALM communication 25-06. Place of performance is Winooski, Vermont.</p>

<p>The NIH Clinical Center awarded a purchase order to Biotek Instruments, Inc. for $14,561.03 on August 7, 2018, under no set-aside. Work is performed in Winooski, Vermont. The order carries firm fixed pricing and an ultimate completion date of August 7, 2018.</p>

<p>The National Institute of Dental and Craniofacial Research awarded a purchase order to Biotek Instruments, Inc. for $53,000 on September 19, 2019, under a Total Small Business set-aside. The order procures a spectrophotometer for conducting biochemical assays, with place of performance in Winooski, Vermont. The contract carries firm fixed pricing and an ultimate completion date of November 18, 2019.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Biotek Instruments, Inc. for $8,594.65 on March 8, 2018, under a firm fixed-price maintenance service agreement renewal. Work is performed in Winooski, Vermont. The order covers field service maintenance under contract CYT3MV, Serial #1312071, with a period of performance from April 3, 2018 to April 2, 2019.</p>

<p>The National Institute of Neurological Disorders and Stroke issued a delivery order to Biotek Instruments, Inc. on July 29, 2017, for a cell imaging system with incubator (LionHeart FX) with a ceiling value of $59,995.</p> <p>The order was issued under the GSA Schedule Scientific Equipment and Services (FSS-66). Place of performance is Bethesda, Maryland. The contract is firm fixed price with an ultimate completion date of September 27, 2017. No set-aside was used.</p>